Harvard Apparatus Regenerative Technology, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 2012-05-03
- Employees
- 18
- Market Cap
- -
- Website
- http://www.biostage.com
Safety and Feasibility Study of the CELLSPAN Esophageal Implant (CEI) in Patients Requiring Short Segment Esophageal Replacement
Phase 1
Recruiting
- Conditions
- Esophageal Diseases
- Interventions
- Combination Product: Cellspan™ Esophageal Implant-Adult (CEI)
- First Posted Date
- 2023-05-26
- Last Posted Date
- 2025-03-28
- Lead Sponsor
- Harvard Apparatus Regenerative Technology, Inc.
- Target Recruit Count
- 10
- Registration Number
- NCT05877300
- Locations
- 🇺🇸
University of Michigan, Ann Arbor, Michigan, United States
🇺🇸Mayo Clinic, Rochester, Minnesota, United States
© Copyright 2025. All Rights Reserved by MedPath